CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of CCI-779 in treating patients who have mantle
cell non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer
cells from dividing so they stop growing or die.